FULCRUM THERAPEUTICS INC (FULC) — insider trading
Health Care · NASDAQ
FULCRUM THERAPEUTICS INC (FULC) has 14 reported SEC Form 4 insider transactions in our data, including 4 open-market purchases and 1 open-market sale among the most recent 14 (latest 2026-07-15).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | TANG KEVIN; TANG CAPITAL MANAGEMENT LLC | 10% owner | Open-market purchase | 107,377 | $3.56 | $382.3K | Form 4 |
| 2026-07-14 | TANG KEVIN; TANG CAPITAL MANAGEMENT LLC | 10% owner | Open-market purchase | 75,952 | $3.58 | $271.9K | Form 4 |
| 2026-07-14 | TANG KEVIN; TANG CAPITAL MANAGEMENT LLC | 10% owner | Open-market purchase | 53,651 | $3.56 | $191.0K | Form 4 |
| 2026-07-13 | TANG KEVIN; TANG CAPITAL MANAGEMENT LLC | 10% owner | Open-market purchase | 12,966 | $3.54 | $45.9K | Form 4 |
| 2026-06-30 | Ezekowitz Alan | Director | Grant / award / vesting (derivative) | 32,000 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Hill Colin | Director | Grant / award / vesting (derivative) | 32,000 | $0.00 | $0 | Form 4 |
| 2026-06-30 | GERAGHTY JAMES A | Director | Grant / award / vesting (derivative) | 32,000 | $0.00 | $0 | Form 4 |
| 2026-06-30 | King Rachel K. | Director | Grant / award / vesting (derivative) | 32,000 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Haviland Kate | Director | Grant / award / vesting (derivative) | 32,000 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Gould Robert J | Director | Grant / award / vesting (derivative) | 32,000 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Dorton Katina | Director | Grant / award / vesting (derivative) | 32,000 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Banks Sonja | Director | Grant / award / vesting (derivative) | 32,000 | $0.00 | $0 | Form 4 |
| 2026-06-26 | Ezekowitz Alan | Director | Open-market sale | 18,000 | $3.65 | $65.6K | Form 4 |
| 2026-04-23 | Lehrer-Graiwer Joshua | Director | Grant / award / vesting (derivative) | 64,000 | $0.00 | $0 | Form 4 |
Ask the chat about FULC's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: FULCRUM THERAPEUTICS INC (FULC).
Last updated 2026-07-15 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.